Evidence map›Paper›PMID 35253628›Full record

ArticleEpigenetics2022

Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA.

Romain Guitton, Christian Dölle, Guido Alves, Tysnes Ole-Bjørn, Gonzalo S Nido, Charalampos Tzoulis

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Mitoepigenetic Alterations in Early-Onset Parkinson's Disease.International journal of molecular sciences · 2026
    Article
  6. Review
  7. Review
  8. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Romain GuittonNeuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0003-1257-4274
Christian DölleNeuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Guido AlvesThe Norwegian Centre for Movement Disorders and Department of Neurology, Stavanger University Hospital, Stavanger, Norway.
Tysnes Ole-BjørnNeuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Gonzalo S NidoNeuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-1766-4108
Charalampos TzoulisNeuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0003-0341-5191
Haukeland University Hospital · NOStavanger University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While DNA methylation is established as a major regulator of gene expression in the nucleus, the existence of mitochondrial DNA (mtDNA) methylation remains controversial. Here, we characterized the mtDNA methylation landscape in the prefrontal cortex of neurological healthy individuals (

Indexed as

DNA, MitochondrialParkinson DiseaseBrainCpG IslandsDNA MethylationHumansSequence Analysis, DNASulfitesDNA, Mitochondrialhydrogen sulfiteSulfitesepigeneticsmitochondriamtDNANUMTsparkinson’s disease

Identifiers

PMID35253628
PMCPMC9423827
OpenAlexW4220970735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.